RE: Condor7 Apr 2016 01:24
Yep you just described a startup!
Episalvan has potential but as of now still has no sales.
I too was at the shareholder meeting and yes it was very professional so we will see over the next 18 months if they get fda approval for treatment of children with this terrible disease.